Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 60Prostatic Neoplasms 10Colorectal Neoplasms 10Breast Carcinoma In Situ 8Uterine Cervical Neoplasms 7Lung Neoplasms 6Colonic Neoplasms 6Rectal Neoplasms 5Depression 5Anatomic Stage I Breast Cancer AJCC v8 5Ovarian Neoplasms 4Neoplasms 4Fatigue 4Endometrial Neoplasms 4Carcinoma, Intraductal, Noninfiltrating 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Pain 3Obesity 3Lymphoma 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms, Male 3Vulvar Neoplasms 2Vaginal Neoplasms 2Pancreatic Neoplasms 2Lymphedema 2Inflammatory Breast Neoplasms 2Genital Neoplasms, Female 2Fallopian Tube Neoplasms 2Carcinoma, Renal Cell 2

Interventions

Psychiatric Rehabilitation 1Methods 1Early Intervention, Educational 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leydig Cell Tumor × Early Intervention, Educational × Breast × Clear all
NCT01764789 2015-10-09

Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Completed
39 enrolled
BreastGynecologic

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Breast Neoplasms, Uterine Cervical Neoplasms, Depression, Fallopian Tube Neoplasms, Fatigue, Leydig Cell Tumor, Pain, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡